Your browser doesn't support javascript.
loading
Predictors of Long-Term Survival among High-Grade Serous Ovarian Cancer Patients.
Clarke, Christina L; Kushi, Lawrence H; Chubak, Jessica; Pawloski, Pamala A; Bulkley, Joanna E; Epstein, Mara M; Burnett-Hartman, Andrea N; Powell, Bethan; Pearce, Celeste L; Spencer Feigelson, Heather.
Afiliação
  • Clarke CL; Institute for Health Research, Kaiser Permanente Colorado, Denver, Colorado. Christina.L.Clarke@kp.org.
  • Kushi LH; Division of Research, Kaiser Permanente Northern California, Oakland, California.
  • Chubak J; Health Research Institute, Kaiser Permanente Washington, Seattle, Washington.
  • Pawloski PA; HealthPartners Institute, Bloomington, Minnesota.
  • Bulkley JE; Center for Health Research, Kaiser Permanente Northwest, Portland, Oregon.
  • Epstein MM; Meyers Primary Care Institute, Worcester, Massachusetts.
  • Burnett-Hartman AN; Department of Medicine, University of Massachusetts Medical School, Worcester, Massachusetts.
  • Powell B; Institute for Health Research, Kaiser Permanente Colorado, Denver, Colorado.
  • Pearce CL; Gynecologic Oncology Program, Kaiser Permanente Northern California, San Francisco, California.
  • Spencer Feigelson H; School of Public Health, University of Michigan, Ann Arbor, Michigan.
Cancer Epidemiol Biomarkers Prev ; 28(5): 996-999, 2019 05.
Article em En | MEDLINE | ID: mdl-30967418
BACKGROUND: Relatively little is known about factors associated with long-term survival (LTS) following a diagnosis of ovarian cancer. METHODS: We conducted a retrospective study of high-grade serous ovarian cancer (HGSOC) to explore predictors of LTS (defined as ≥7 years of survival) using electronic medical record data from a network of integrated health care systems. Multivariable logistic regression with forward selection was used to compare characteristics of women who survived ≥7 years after diagnosis (n = 148) to those who died within 7 years of diagnosis (n = 494). RESULTS: Our final model included study site, age, stage at diagnosis, CA-125, comorbidity score, receipt of chemotherapy, BMI, and four separate comorbid conditions: weight loss, depression, hypothyroidism, and liver disease. Of these, only younger age, lower stage, and depression were statistically significantly associated with LTS. CONCLUSIONS: We did not identify any new characteristics associated with HGSOC survival. IMPACT: Prognosis of ovarian cancer generally remains poor. Large, pooled studies of ovarian cancer are needed to identify characteristics that may improve survival.
Assuntos

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Neoplasias Ovarianas / Cistadenocarcinoma Seroso / Sobreviventes de Câncer Tipo de estudo: Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Adolescent / Adult / Aged / Female / Humans / Middle aged País/Região como assunto: America do norte Idioma: En Revista: Cancer Epidemiol Biomarkers Prev Assunto da revista: BIOQUIMICA / EPIDEMIOLOGIA / NEOPLASIAS Ano de publicação: 2019 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Neoplasias Ovarianas / Cistadenocarcinoma Seroso / Sobreviventes de Câncer Tipo de estudo: Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Adolescent / Adult / Aged / Female / Humans / Middle aged País/Região como assunto: America do norte Idioma: En Revista: Cancer Epidemiol Biomarkers Prev Assunto da revista: BIOQUIMICA / EPIDEMIOLOGIA / NEOPLASIAS Ano de publicação: 2019 Tipo de documento: Article